Harvard Bioscience (HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, announced that its wholly-owned subsidiary, Harvard Apparatus Regenerative Technology, Inc.
FORBES: Harvard Bioscience Announces Filing of IPO Registration Statement for Harvard Apparatus Regenerative Technology